Unbound MEDLINE

Aberrant Changes of Wnt2/beta-Catenin Signaling Pathway Induced by Sodium Nitroprusside in Human Esophageal Squamous Cell Carcinoma Cell Lines. Cancer investigation [Cancer Invest] Journal article

 
TitleAberrant Changes of Wnt2/beta-Catenin Signaling Pathway Induced by Sodium Nitroprusside in Human Esophageal Squamous Cell Carcinoma Cell Lines.
Author(s)Wang W, Xue L, Liu H, Wang P, Xu P, Cai Y 
InstitutionLaboratory for Cell Biology, The First Affiliated Hospital, Zhengzhou University, 40 Daxue Road, Zhengzhou, Henan 450052, China 1.
SourceCancer Invest 2009 Oct 26.
AbstractABSTRACT Inhibition of Wnt/beta-catenin pathway is an attractive method for therapy of various tumors including breast, colorectal, and cervical cancer, etc. However, little is known about the role of Wnt2/beta-catenin pathway in esophageal squamous cell carcinoma (ESCC). Here we identify that Wnt2/beta-catenin signaling pathway is activated in ESCC cells, and sodium nitroprusside (SNP) and siRNA against beta-catenin not only inhibit the expressions of beta-catenin and its major downstream effectors including c-myc and cyclin D1, but induce cell cycle arrest and apoptosis, suggesting that Wnt2/beta-catenin pathway may be a potential molecular target for ESCC therapy.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19857041
  
Advertise on this site.